Diffuse large B-cell lymphoma: a heterogeneous group of non-Hodgkin lymphomas comprising several distinct clinicopathological entities (Q36622610)

15 August 2017

1 reference

title

Diffuse large B-cell lymphoma: a heterogeneous group of non-Hodgkin lymphomas comprising several distinct clinicopathological entities (English)

1 reference

diffuse large B-cell lymphoma

15 August 2017

1 reference

1 reference

De Paepe P

1

1 reference

PubMed ID

17039226

15 August 2017

De Wolf-Peeters C

series ordinal

2

1 reference

15 August 2017

12 October 2006

1 reference

15 August 2017

1 reference

15 August 2017

21

1 reference

15 August 2017

37-43

1 reference

15 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404449

15 August 2017

0 references

cites work

Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

Clinicopathologic significance and prognostic value of chromosomal imbalances in diffuse large B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

Immunohistochemical expression of CD10 and t(14;18) chromosomal translocation may be indicators of follicle centre cell origin in nodal diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

CD10 and Bcl10 expression in diffuse large B-cell lymphoma: CD10 is a marker of improved prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

Large cleaved and immunoblastic lymphoma may represent two distinct clinicopathologic entities within the group of diffuse large B-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

A spindle cell variant of diffuse large B-cell lymphoma possesses genotypic and phenotypic markers characteristic of a germinal center B-cell origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

Timely topic: anaplastic lymphoma kinase (ALK) spreads its influence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

Translocations involving anaplastic lymphoma kinase (ALK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

Pyothorax-associated lymphoma: a review of 106 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

Pyothorax-associated lymphoma: a peculiar clinicopathologic entity derived from B cells at late stage of differentiation and with occasional aberrant dual B- and T-cell phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

Diffuse large B-cell lymphomas with plasmablastic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

WHO-EORTC classification for cutaneous lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

Updated Kiel classification for lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

7 January 2021

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

7 January 2021

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

7 January 2021

A predictive model for non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

7 January 2021

The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

7 January 2021

BCL-6 expression in reactive lymphoid tissue and in B-cell non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

7 January 2021

Bcl-6 and Bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: correlation with 3q27 and 18q21 chromosomal abnormalities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

7 January 2021

FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

7 January 2021

A Case of a Diffuse Large B-Cell Lymphoma of Plasmablastic Type Associated With the t(2;5)(p23;q35) Chromosome Translocation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

7 January 2021

ALK-positive diffuse large B-cell lymphoma of the stomach associated with a clathrin-ALK rearrangement

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

7 January 2021

ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

7 January 2021

T-cell-rich B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

7 January 2021

Histiocyte-rich, T-cell-rich B-cell lymphoma: a distinct diffuse large B-cell lymphoma subtype showing characteristic morphologic and immunophenotypic features

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

7 January 2021

AIDS-related lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

7 January 2021

Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404449

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404449

1 reference

15 August 2017

1 reference

PubMed ID

17039226